Abbott Laboratories (ABT) stock Forecast for 2022 – 2026
Last update: 05-21-2022, 8:42Sector: Healthcare
The share price of Abbott Laboratories (ABT) now
What analysts predict:: $121.06
52-week high/low: $115.14 / $60.9114
50/200 Day Moving Average: $108.3297 / $104.3559
This figure corresponds to the average price over the previous 50/200 days. For Abbott Laboratories stocks, the 50-day moving average is the support level today.
For Abbott Laboratories stocks, the 200-day moving average is the support level today.
Are you interested in Abbott Laboratories stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Abbott Laboratories stock price in 2022, 2023, 2024, 2025, 2026. How much will one Abbott Laboratories share be worth in 2022 - 2026?
When should I take profit in Abbott Laboratories stock? When should I record a loss on Abbott Laboratories stock? What are analysts' forecasts for Abbott Laboratories stock? What is the future of Abbott Laboratories stock?
We forecast Abbott Laboratories stock performance using neural networks based on historical data on Abbott Laboratories stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Abbott Laboratories stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Abbott Laboratories shares. This happens once a day.
Historical and forecast chart of Abbott Laboratories stock
The chart below shows the historical price of Abbott Laboratories stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Abbott Laboratories stock price can be found in the table below.
Long-term forecasts by years.
Abbott Laboratories daily forecast for a month
Abbott Laboratories Daily Price Targets
Abbott Laboratories Stock Forecast 05-23-2022.
Pessimistic target level: 110.17
Optimistic target level: 112.88
Abbott Laboratories Stock Forecast 05-24-2022.
Pessimistic target level: 109.42
Optimistic target level: 112.40
Abbott Laboratories Stock Forecast 05-25-2022.
Pessimistic target level: 107.47
Optimistic target level: 110.40
Abbott Laboratories Stock Forecast 05-26-2022.
Pessimistic target level: 105.56
Optimistic target level: 108.51
Abbott Laboratories Stock Forecast 05-27-2022.
Pessimistic target level: 106.72
Optimistic target level: 109.39
Abbott Laboratories Stock Forecast 05-28-2022.
Pessimistic target level: 108.71
Optimistic target level: 111.94
ABT (ABT) Monthly Stock Prediction for 2022
Abbott Laboratories forecast for this year
Abbott Laboratories Stock Prediction for Jun 2022
An uptrend is forecast for this month with an optimal target price of $120.677. Pessimistic: $113.15. Optimistic: $125.31
Abbott Laboratories Stock Prediction for Jul 2022
An downtrend is forecast for this month with an optimal target price of $119.808. Pessimistic: $116.07. Optimistic: $125.75
Abbott Laboratories Stock Prediction for Aug 2022
An downtrend is forecast for this month with an optimal target price of $118.658. Pessimistic: $113.63. Optimistic: $125.78
Abbott Laboratories Stock Prediction for Sep 2022
An uptrend is forecast for this month with an optimal target price of $122.74. Pessimistic: $118.42. Optimistic: $129.02
Abbott Laboratories Stock Prediction for Oct 2022
An downtrend is forecast for this month with an optimal target price of $116.259. Pessimistic: $109.47. Optimistic: $122.77
Abbott Laboratories Stock Prediction for Nov 2022
An downtrend is forecast for this month with an optimal target price of $113.283. Pessimistic: $109.30. Optimistic: $119.63
Abbott Laboratories Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $121.349. Pessimistic: $119.31. Optimistic: $124.16
Abbott Laboratories (ABT) Monthly Stock Prediction for 2023
Abbott Laboratories (ABT) Monthly Stock Prediction for 2024
Abbott Laboratories (ABT) Monthly Stock Prediction for 2025
Abbott Laboratories (ABT) Monthly Stock Prediction for 2026
Abbott Laboratories information and performance
Abbott Laboratories manufactures drugs, medical devices and diagnostic tools – tests for immunity and blood tests that are used in clinics and hospitals in N countries. The first HIV test was developed by Abbott.
Business publications and major stock indices recognize Abbott Laboratories’ contributions: Fortune magazine has ranked the company as one of the most respected in the world every year since 1984.
The company was founded in 1888. The University of Michigan graduate Wallace Abbott worked as a medical practitioner and opened his own pharmacy. He introduced a new way of using alkaloids of medicinal plants: he formed granules from them with micro doses. Treatment with these granules helped patients because the doses of the drug were accurate and the effect was predictable and consistent.
Abbott Laboratories Address
100 Abbott Park Road, North Chicago, IL, United States, 60064
Market Capitalization: 196 439 506 944 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: 7 823 000 064 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: 58.6118
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: 3.433
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: 0.302
Quarterly Revenue Growth YOY: 0.096
Trailing PE: 58.6118
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: 24.8139
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 6.431
Enterprise Value (EV) /Revenue
EV To EBITDA: 27.2256
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 1772359936
Number of issued ordinary shares
Shares Float: 1758413095
Number of freely tradable shares
Shares Short Prior Month: 11849490
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: 1.83
Percent Insiders: 0.693
Percent Institutions: 75.579
Abbott Laboratories (ABT) stock dividend
Abbott Laboratories last paid dividends on 01/14/2021. The next scheduled payment will be on 02/16/2021. The amount of dividends is $1.8 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Factor: 10000:4798
Last Split Date: 01/02/2013
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.